Moderna (MRNA) Free Cash Flow (QoQ) (2018 - 2026)
Moderna (MRNA) Free Cash Flow (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Moderna | 22.52 Bn | 17.32 Bn | -566.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -174.64% |
| Dec 31, 2025 | 193.49% |
| Sep 30, 2025 | -12.25% |
| Jun 30, 2025 | 26.43% |
| Mar 31, 2025 | -243.18% |
| Dec 31, 2024 | 163.67% |
| Sep 30, 2024 | 13.05% |
| Jun 30, 2024 | -22.87% |
| Mar 31, 2024 | -1,980.95% |
| Dec 31, 2023 | 103.83% |
| Sep 30, 2023 | -81.15% |
| Jun 30, 2023 | 32.21% |
| Mar 31, 2023 | -185.22% |
| Dec 31, 2022 | 863.19% |
| Sep 30, 2022 | 9.40% |
| Jun 30, 2022 | -94.48% |
| Mar 31, 2022 | -17.34% |
| Dec 31, 2021 | -0.31% |
| Sep 30, 2021 | -18.51% |
| Jun 30, 2021 | 36.24% |